ARYA Sciences Acquisition Corp III (ARYA)

Etorro trading 970x250

About ARYA Sciences Acquisition Corp III

ARYA Sciences Acquisition Corp III intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2020 and is based in New York, New York. Address: 51 Astor Place, New York, NY, United States, 10003

ARYA Sciences Acquisition Corp III News and around…

Latest news about ARYA Sciences Acquisition Corp III (ARYA) common stock and company :

Last Week's Notable Insider Buys: Lululemon Athletica, Opendoor Technologies And More
13 Jun, 2021 FinancialContent

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. A SPAC, a ...

The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal
10 Jun, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome
10 Jun, 2021 FinancialContent
The Past Week's Notable Insider Buys: Dun & Bradstreet, Norfolk Southern, And More
06 Jun, 2021 FinancialContent

Note that with the earnings reporting season officially over, insiders overall are no longer prohibited from buying or selling shares. Here are some of the most noteworthy insider purchases that were reported in the past week.

The Past Week's Notable Insider Buys: Dun & Bradstreet, Norfolk Southern And More
06 Jun, 2021 FinancialContent

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. A SPAC, a ...

ARYA Sciences Acquisition Corp III Announces Extraordinary General Meeting Teleconference Details
01 Jun, 2021 FinancialContent
Stocks That Hit 52-Week Lows On Friday
07 May, 2021 FinancialContent

Friday's morning session saw 17 companies set new 52-week lows. Key Facts: Beyond Meat (NASDAQ:BYND) ...

Nautilus Biotechnology Appoints Matt Murphy as General Counsel
06 Apr, 2021 FinancialContent

Nautilus Biotechnology appoints Matt Murphy, former 10x Genomics and Pacific Biosciences executive, as General Counsel

How to find the most promising SPACs and dodge the hidden dangers
26 Feb, 2021 FinancialContent

The track record of the sponsors and the investors involved is key.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of ARYA Sciences Acquisition Corp III Merger
12 Feb, 2021 FinancialContent
92 Biggest Movers From Yesterday
10 Feb, 2021 FinancialContent

Gainers Applied UV, Inc. (NASDAQ: AUVI) shares surged 280.5% to close at $19.71 on Tuesday. The company earlier announced closing ...

70 Stocks Moving In Tuesday's Mid-Day Session
09 Feb, 2021 FinancialContent

Gainers Applied UV, Inc. (NASDAQ: AUVI) shares jumped 325.7% to $22.05. The company earlier announced closing on acquisition of ...

105 Biggest Movers From Yesterday
09 Feb, 2021 FinancialContent

Gainers Ocugen, Inc. (NASDAQ: OCGN) shares jumped 201.1% to close at $15.81 on Monday after announcing the sale of 3 million ...

Mid-Afternoon Market Update: Dow Surges 140 Points; Ocugen Shares Spike Higher
08 Feb, 2021 FinancialContent

Toward the end of trading Monday, the Dow traded up 0.45% to 31,288 while the NASDAQ rose 0.48% to 13,922.14. The S&P also rose, ...

Mid-Day Market Update: Crude Oil Rises Over 2%; AMC Entertainment Shares Slide
08 Feb, 2021 FinancialContent

Midway through trading Monday, the Dow traded up 0.46% to 31,292.52 while the NASDAQ rose 0.56% to 13,933.76. The S&P also rose, ...

70 Stocks Moving In Monday's Mid-Day Session
08 Feb, 2021 FinancialContent

Gainers Ocugen, Inc. (NASDAQ: OCGN) shares climbed 183.2% to $14.87 after announcing the sale of 3 million common shares at $7.65 ...

Why Moderna, Avrobio, And More Are Moving Today
08 Feb, 2021 FinancialContent

Moderna (NASDAQ: MRNA) shares are trading higher amid South Africa stopping distribution of the AstraZeneca COVID-19 vaccine due to ...

Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III
08 Feb, 2021 FinancialContent

Nautilus Biotechnology, Inc. ("Nautilus Biotechnology" or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, and Arya Sciences Acquisition Corp III (Nasdaq: ARYA) (“Arya III”), a special purpose acquisition company or SPAC, sponsored by Perceptive Advisors, today announced they have entered into a definitive business combination agreement. Upon closing of the transaction, Arya III will redomicile as a Delaware corporation, be renamed Nautilus Biotechnology, Inc. and its common stock is expected to be listed on Nasdaq under the ticker symbol “NAUT” (the “Combined Company”).

ARYA Sciences Acquisition Corp III (ARYA) is a NASDAQ Common Stock listed in , ,

970x250